Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€43.86

€43.86

0.640%
0.28
0.640%
€49.02
 
26.04.24 / Tradegate WKN: 870353 / Symbol: STAA / Name: STAAR Surgical / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Staar Surgical Co. Stock

The Staar Surgical Co. stock is trending slightly upwards today, with an increase of €0.28 (0.640%) compared to yesterday's price.
With 11 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 49 € there is a slightly positive potential of 11.72% for Staar Surgical Co. compared to the current price of 43.86 €.

Pros and Cons of Staar Surgical Co. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
C******** o* t** e**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Staar Surgical Co. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Staar Surgical Co. 0.640% -0.569% 27.389% -31.985% 50.603% -60.488% -
Orasure Tech -0.980% 4.508% -11.304% -18.400% -31.544% -36.928% -40.028%
scPharmaceuticals -7.800% 9.000% -7.627% -51.556% -24.174% -20.727% -
SI-BONE Inc -2.140% -0.709% -0.709% -26.702% -26.316% -51.049% -

Comments

Prediction Buy
Perf. (%) -8.78%
Target price 49.327
Change
Ends at 11.04.25

STAAR Surgical (NASDAQ: STAA) had its price target raised by analysts at Mizuho from $45.00 to $53.00. They now have a "buy" rating on the stock.
Ratings data for STAA provided by MarketBeat
Show more

STAAR Surgical (NASDAQ: STAA) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Ratings data for STAA provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 20.07%
Target price 46.565
Change
Ends at 01.04.25

STAAR Surgical (NASDAQ: STAA) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $50.00 price target on the stock.
Ratings data for STAA provided by MarketBeat
Show more

News

STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today

STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024: https://mms.businesswire.com/media/20240402599401/en/2086323/5/Image_1_STAAR_Will-Levis-Invite_1x1.jpg
STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL) for myopia, astigmatism and presbyopia, comes to

STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses: https://mms.businesswire.com/media/20240318771746/en/2069563/5/EVO_-_3M_Lens_commas.jpg
STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today